Genetic Studies in the Hutterites

Request Access

Anthropometry (1)

BMI - Body mass index (phv00395569.v1.p1)

Demographics (7)

age - Age at time of collection (phv00200329.v2.p1)
age - Age of subject (phv00395585.v1.p1)
Age - Age at collection (phv00395573.v1.p1)
sex - Gender of participant (phv00200330.v2.p1)
sex - Sex of subject (phv00395584.v1.p1)
sex - Gender of participant (phv00190477.v2.p1)
Sex - Sex (phv00395572.v1.p1)

Disease Events (1)

asthma - Diagnosed with asthma (phv00190478.v2.p1)

Other (68)

ANALYTE_TYPE - Analyte Type (phv00200338.v1.p1)
ANALYTE_TYPE - Analyte Type (phv00395594.v1.p1)
ANALYTE_TYPE - Analyte Type (phv00395600.v1.p1)
ANALYTE_TYPE - Analyte Type (phv00430124.v1.p1)
ANALYTE_TYPE - Analyte Type (phv00430131.v1.p1)
ANALYTE_TYPE - Analyte Type (phv00190481.v1.p1)
ANALYTE_TYPE - Analyte Type (phv00273515.v1.p1)
ANTIBIOTICS - Indicates whether the person has taken antibiotics 6 months prior to sampling (phv00200336.v1.p1)
BMI_residuals - Body mass index residuals (phv00395570.v1.p1)
BODY_SITE - Body site where sample was collected (phv00200337.v1.p1)
BODY_SITE - Body site where sample was collected (phv00395595.v1.p1)
BODY_SITE - Body site where sample was collected (phv00395599.v1.p1)
BODY_SITE - Body site where sample was collected (phv00430123.v1.p1)
BODY_SITE - Body site where sample was collected (phv00430130.v1.p1)
BODY_SITE - Body site where sample was collected (phv00190480.v1.p1)
BODY_SITE - Body site where sample was collected (phv00273514.v1.p1)
Bodysite - Nasal site of sample collected (Nasopharyx or Vestibule) (phv00395579.v1.p1)
CASAVA_VERSION - The version of CASAVA used for base calling (phv00200335.v1.p1)
CONSENT - Consent group as determined by DAC (phv00190446.v5.p1)
Date_of_collection - Factor that groups samples collected on the same day (phv00395576.v1.p1)
DOX - The concentration of doxorubicin added to cells (phv00395603.v1.p1)
filename - Name of FastQ sequence file (phv00395582.v1.p1)
Final_Conc - DNA concentration prior to 16S PCR (phv00395577.v1.p1)
fragment_size - Average DNA fragment bp size prior to sequencing (phv00395578.v1.p1)
GENOTYPING_CENTER - Name of the center which conducted genotyping (phv00430127.v1.p1)
GENOTYPING_CENTER - Name of the center which conducted genotyping (phv00430134.v1.p1)
Group - Body site/Season combination (phv00395581.v1.p1)
HISTOLOGICAL_TYPE - Cell or tissue type or subtype of sample (phv00395593.v1.p1)
HISTOLOGICAL_TYPE - Cell or tissue type or subtype of sample (phv00395602.v1.p1)
HISTOLOGICAL_TYPE - Cell or tissue type or subtype of sample (phv00430126.v1.p1)
HISTOLOGICAL_TYPE - Cell or tissue type or subtype of sample (phv00430133.v1.p1)
IS_TUMOR - Tumor status (phv00395596.v1.p1)
IS_TUMOR - Tumor status (phv00395601.v1.p1)
IS_TUMOR - Tumor status (phv00430125.v1.p1)
IS_TUMOR - Tumor status (phv00430132.v1.p1)
IS_TUMOR - Tumor status (phv00190482.v1.p1)
IS_TUMOR - Tumor status (phv00273516.v1.p1)
PUBLICATION - PMID and study description (phv00273512.v3.p1)
RNA_EXTRACTION_BATCH - Batch in which RNA was extracted (phv00395591.v1.p1)
rs1801274_counts_A_allele - Rs1801274 genotype by count of A allele (phv00395586.v1.p1)
rs1801274_genotype - Rs1801274 genotype (phv00395587.v1.p1)
SAMPLE_ID - De-identified Sample ID (phv00200331.v1.p1)
SAMPLE_ID - De-identified Sample ID (phv00395574.v1.p1)
SAMPLE_ID - De-identified Sample ID (phv00395588.v1.p1)
SAMPLE_ID - De-identified Sample ID. One for each combination of SUBJECT_ID and DOX. (phv00395597.v1.p1)
SAMPLE_ID - Sample ID (phv00430122.v1.p1)
SAMPLE_ID - Sample ID (phv00430129.v1.p1)
SAMPLE_ID - De-identified Sample ID (phv00190479.v2.p1)
SAMPLE_ID - De-identified Sample ID (phv00273513.v2.p1)
SAMPLE_ID - Sample ID (phv00190453.v5.p1)
Season - Season when sample was collected (Summer or Winter) (phv00395580.v1.p1)
SEASON - Season of sample collection (phv00200333.v1.p1)
SEQ_POOL - Sequencing pool for RNAseq submission (phv00395592.v1.p1)
SEQUENCING_CENTER - Name of the center which conducted sequencing (phv00430128.v1.p1)
SEQUENCING_CENTER - Name of the center which conducted sequencing (phv00430135.v1.p1)
SUBJECT_ID - De-identified Subject ID (phv00200332.v1.p1)
SUBJECT_ID - De-identified Subject ID (phv00395575.v1.p1)
SUBJECT_ID - De-identified Subject ID (phv00395589.v1.p1)
SUBJECT_ID - De-identified Subject ID (phv00395598.v1.p1)
SUBJECT_ID - De-identified Subject ID (phv00200328.v2.p1)
SUBJECT_ID - De-identified Subject ID (phv00395583.v1.p1)
SUBJECT_ID - Subject ID (phv00190452.v5.p1)
SUBJECT_ID - De-identified Subject ID (phv00190476.v3.p1)
SUBJECT_ID - De-identified Subject ID (phv00395571.v1.p1)
SUBJECT_ID - Subject ID (phv00190445.v5.p1)
TECH_REP - Indicates which technical replicate sample is (phv00200334.v1.p1)
TREATMENT - Sample was incubated in media + treatment for 30 hours, either untreated control (untreated_ctrl) or anti-CD3 and anti-CD28 antibodies (aCD3_aCD28) (phv00395590.v1.p1)
TUMOR_STATUS - Tumor status (phv00200339.v1.p1)